Cite
HARVARD Citation
Pakkala, S. et al. (2020). Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study. Journal for immunotherapy of cancer. 8 (2), p. . [Online].